Condition: Healthy Participants · Obese But Otherwise Healthy Participants · Sponsor: Touro University, California
This study will test the hypothesis that within a defined range of fructose intake, the ability to convert fructose to glucose (via gluconeogenesis) in the small intestine plays a protective role for the liver, shielding it from the deleterious effects of fructose. We will investigate whether this protective effect of the intestine is impaired in individuals with obesity.
This description comes directly from the study's public registry record.
Sally Chiu, PhD · 707-638-5404 · schiu2@touro.edu
Lisa Johnson, RN · ljohnson19@touro.edu
Always discuss trial participation with your own doctor first.
| Touro University California | Vallejo, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07209202